Why the study?
Do cardiac biomarkers (BNP and TnT) predict cardiovascular mortality in asymptomatic predialysis CKD patients?
Do cardiac biomarkers (BNP and TnT) predict cardiovascular mortality in asymptomatic predialysis CKD patients?
BNP and TnT are independent predictors of cardiovascular mortality and can be used to stratify cardiovascular risk in asymptomatic patients with advanced predialysis chronic kidney disease.
No takes yet. Share an insight, caveat, or question.
May support risk stratification with BNP/TnT in predialysis CKD; hypothesis-generating and requires prospective validation before practice change.
Tirmenštajn‐Janković et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: